FDA Approved Products
1,302 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
EVEKEO ODT
amphetamine sulfate
Peak
R-Pharm US
ORAL · TABLET, ORALLY DISINTEGRATING
Attention Deficit Hyperactivity Disorder (ADHD) in patients 13 yearsolder+1
2019
NDA0/100
EVOMELA
melphalan
Peak
Acrotech Biopharma
INTRAVENOUS · POWDER
myeloma
2016
NDA0/100
EVOTAZ
atazanavir and cobicistat
Peak
Bristol Myers Squibb
ORAL · TABLET
2015
SMNDA0/100
EVRYSDI
risdiplam
Peak
Roche
ORAL · FOR SOLUTION
spinal muscular atrophy (SMA) in pediatric
2020
NDA0/100
EVZIO
naloxone hydrochloride
Peak
INTRAMUSCULAR, SUBCUTANEOUS · SOLUTION
depression
2014
NDA0/100
EVZIO (AUTOINJECTOR)
naloxone hydrochloride
Peak
INTRAMUSCULAR, SUBCUTANEOUS · SOLUTION
2016
NDA0/100
EXEM FOAM KIT
air polymer-type a intrauterine foam
Peak
INTRAUTERINE · FOAM
2019
NDA0/100
EXKIVITY
mobocertinib succinate
Peak
Takeda
ORAL · CAPSULE
2021
NDA0/100
EXONDYS 51
eteplirsen
Peak
INTRAVENOUS · SOLUTION
Duchenne muscular dystrophy (DMD) in patients
2016
RNANDA0/100
EXPAREL
bupivacaine
Peak
INJECTION · INJECTABLE, LIPOSOMAL
2011
NDA0/100
EYSUVIS
loteprednol etabonate
Peak
Alcon
OPHTHALMIC · SUSPENSION/DROPS
2020
NDA0/100
EZALLOR SPRINKLE
rosuvastatin
Peak
Fosun Pharma
ORAL · CAPSULE
2018
SMNDA0/100
FANAPT
iloperidone
Peak
Vanda Pharmaceuticals
ORAL · TABLET
schizophrenia
2009
NDA0/100
FARXIGA
dapagliflozin
Peak
AstraZeneca
ORAL · TABLET
type 2 diabetes mellitustype 1 diabetes mellitus+2
2014
SMNDA0/100
FENSOLVI KIT
leuprolide acetate
Peak
Tolmar
SUBCUTANEOUS · POWDER
older with central precocious puberty
2020
NDA0/100
FERRIPROX
deferiprone
Peak
Chiesi
ORAL · TABLET
2020
NDA0/100
FETROJA
cefiderocol sulfate tosylate
Peak
Shionogi
INTRAVENOUS · POWDER
older for the treatment of complicated urinary tract infections (cUTIs)including pyelonephritis caused by the following susceptible Gram-negative microorganisms: Escherichia coli+8
2019
NDA0/100
FETZIMA
levomilnacipran hydrochloride
Peak
AbbVie
ORAL · CAPSULE, EXTENDED RELEASE
Major Depressive Disorder (MDD) in adults ()
2013
NDA0/100
FINTEPLA
fenfluramine
Peak
UCB Pharma
ORAL · SOLUTION
seizures associated with Dravet syndromeLennox-Gastaut syndrome in patients 2 years of age+1
2020
NDA0/100
FIRDAPSE
amifampridine phosphate
Peak
Catalyst Pharmaceuticals
ORAL · TABLET
Lambert-Eaton myasthenic syndrome (LEMS) in adultsolder
2018
NDA0/100
FIRMAGON
degarelix
Peak
Ferring Pharmaceuticals
SUBCUTANEOUS · POWDER
prostate cancer
2008
NDA0/100
FIRVANQ KIT
vancomycin hydrochloride
Peak
R-Pharm US
ORAL · FOR SOLUTION
enterocolitis caused by Staphylococcus aureus (including methicillin‑resistant strains) in adults
2018
NDA0/100
FLEQSUVY
baclofen
Peak
R-Pharm US
ORAL · SUSPENSION
2022
NDA0/100
FLUORESCEIN SODIUM AND BENOXINATE HYDROCHLORIDE
fluorescein sodium and benoxinate hydrochloride
Peak
Bausch + Lomb
OPHTHALMIC · SOLUTION/DROPS
2020
NDA0/100